Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Tesco LFL sales grow as market share increases

(Sharecast News) - Supermarket chain Tesco said on Thursday that like-for-like sales had grown across the group as it continued to deliver market share gains. Group LFL sales were up 4.6% at £16.38bn, with LFL sales in the UK growing 5.1% to £12.3bn, while Ireland LFL sales were up 5.5% at £772.0m and Central Europe LFL sales improved 4.1% to £997.0m.

UK market share grew by 44 basis points year-on-year to 28.0%, with 24 consecutive four-week periods of share gains, while overall UK brand perception improved by 65 basis points year-on-year.

Food sales were up 5.9%, with a strong contribution from fresh food, while non-food sales grew 6.2% thanks to solid growth in home and clothing.

Tesco also reported growth across all channels, led by its online segment, where sales were up 11.5% and market share improved 163 basis points as the FTSE 100-listed group increased capacity and saw improving customer satisfaction.

Chief executive Ken Murphy said: "We are pleased with our performance across the first quarter. Our continued commitment to delivering great value, quality and service for our customers has contributed to like-for-like sales growth across all parts of the group.

"The market remains intensely competitive, and we are committed to ensuring customers get the best value in the market by shopping at Tesco."

As of 0745 BST, Tesco shares were untraded at 386.50p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.